From Struggle to Success: How Brooklyn Brewery Went International
Cheddar catched up with Brooklyn Brewery co-founder and chairman Steve Hindy at the Cornell Entrepreneurship Summit in New York. Hindy tells us all about his incredible career path from Middle East war correspondent at the Associate Press to co-founding one of the top craft breweries in the country. Hindy says he was inspired by home brewers he met in Cairo before joining the movement himself.
Plus, we also break down the company's thriving international business. Hindy tells us why such a local brand is catching on overseas. Plus, Hindy gave Cheddar a look at the company's 2017 business figures, including how the brewery is set to produce more than 300,000 barrels of beer.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
